CRNX - Crinetics Pharmaceuticals, Inc.
IEX Last Trade
53.69
0.080 0.149%
Share volume: 8,980
Last Updated: Thu 26 Dec 2024 08:29:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$53.61
0.08
0.15%
Summary score
11%
Profitability
8%
Dept financing
3%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.31%
Return on assets
-11.38%
Return on sales
-7292.8%
Return on invested capital
208.76%
Total debt ratio
9.41%
Debt ratio change over timeo
-0.98%
Current Ratio
16.04%
Quick Ratio
15.69%
Cash Position Ratio
15.22%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.34%
Return on assets
-11.16%
Return on sales
-11299.38%
Return on invested capital
-273.77%
Total debt ratio
13.42%
Debt ratio change over timeo
-1.02%
Current Ratio
13.44%
Quick Ratio
13.44%
Cash Position Ratio
12.98%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.65%
Return on assets
-7.52%
Return on sales
-11488.91%
Return on invested capital
-730.84%
Total debt ratio
10.55%
Debt ratio change over time
-1.03%
Current Ratio
17.72%
Quick Ratio
17.72%
Cash Position Ratio
17.4%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.85%
Return on assets
-102.66%
Return on sales
-518.17%
Return on invested capital
9.14%
Total debt ratio
-98.46%
Debt ratio change over time
-0.98%
Current Ratio
2.5%
Quick Ratio
2.4%
Cash Position Ratio
2.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRNX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.31% | 13.79% | 34.47% | 7.43% |
| Return on assets | -11.38% | 2.76% | 3.15% | 5.62% |
| Return on sales | -7292.8% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 208.76% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 9.41% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.98% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 13.44% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 13.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 12.98% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 7% | 16% |
| Short-term ratios | CRNX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.34% | 13.77% | 13.25% | 3.8% |
| Return on assets | -11.16% | 2.43% | 1.89% | 3.09% |
| Return on sales | -11299.38% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -273.77% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 13.42% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.02% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 13.44% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 13.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 12.98% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 10% | 24% |